EVENT: The second annual Epigenetic Control and Cellular Plasticity symposium will focus on how epigenetic control and chromatin remodeling contribute to various processes that lead to cellular plasticity.
WHEN/WHERE: Thursday & Friday, Dec. 12-13, at the At the Beckman Center of the National Academies of Sciences and Engineering in Irvine, Calif.
INFORMATION: Media planning to attend should contact Catherine Cao at firstname.lastname@example.org or 949-824-2961. Attendance and parking are complimentary for media who RSVP in advance. For more information: http://www.
HIGHLIGHTS: Speakers include:
Shelley L. Berger, PhD, University of Pennsylvania
Gerald Crabtree, MD, Stanford University
Jean-Marc Egly, PhD, IGBMC, INSERM (Strasbourg, France)
Ronald M. Evans, PhD, Salk Institute for Biological Studies
Gordon Hager, National Cancer Institute, National Institutes of Health
Juan Carlos Izpisua Belmonte, PhD, Salk Institute for Biological Studies
James T. Kadonaga, PhD, University of California, San Diego
Peter Kaiser, PhD, University of California, Irvine
Mitchell A. Lazar, MD, PhD, University of Pennsylvania
Barbara J. Meyer, PhD, University of California, Berkeley
Ali Mortazavi, PhD, University of California, Irvine
Valerio Orlando, PhD, King Abdullah University of Science and Technology (Thuwal, Saudi Arabia)
Barbara Panning, PhD, University of California, San Francisco
J. Andrew Pospisilik, PhD, Max Planck Institute of Immunobiology and Epigenetics (Freiburg, Germany)
Eric M. Verdin, MD, University of California, San Francisco
Yi Zhang, PhD, Harvard Medical School
Workshop on Biocomputing in Genomics and Epigenomics
Pierre Baldi, PhD, University of California, Irvine
Matteo Pellegrini, PhD, University of California, Los Angeles
Xuegang Sun, PhD, Zymo Research Corporation
The symposium Facebook page includes links to speakers' websites. Please visit: https:/
BACKGROUND: This two-day symposium will focus on how epigenetic control and chromatin remodeling contribute to various processes that lead to cellular plasticity. The understanding of the molecular mechanisms responsible for this level of control is likely to bring essential information for future strategies in pharmacology, stem cell biology and therapeutics.
The symposium will be followed by a workshop on emerging methodologies and the use of biocomputing in genomics and epigenomics.
This meeting marks the collaboration between the Institut de la Santé et de la Recherche Médicale (INSERM) of France, and the University of California, Irvine, which has led to the creation of the research unit U904 "Contrôle Epigénétique de la Plasticité Neuronale."
The Symposium is organized by the Center for Epigenetics and Metabolism, together with INSERM Unité 904, the Institute for Genomics and Bioinformatics, and the Department of Biological Chemistry. Sponsors of this event include the Della Martin Foundation, the Office for Science and Technology of the Embassy of France in the United States, Zymo Research, New England Biolabs, King Abdullah University of Science and Technology (Saudi Arabia), Max Planck Institute (Germany), Active Motif, Covaris, Biocrates, Cell Signaling Technology, and Leica Microsystems.
A meeting report of the Symposium will be published in Epigenetics after the event.